The imperative to pursue academic, government, industry collaboration in accelerating advanced medical technology translation

[CC-Conrad Clyburn-MedForeSight]

To sustain competitiveness recent studies indicate that we need to apply new models of life science collaboration between academic generators of innovation & IP, industry colonizers that take the risk out of innovation, consolidators that have global reach in distribution, marketing & access to public capital, and government for the funding of basic research/applied research and the regulation of new technology to the market.